|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT 32.1
        CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
        AS ADOPTED PURSUANT TO SECTION 906 OF THE
        SARBANES-OXLEY ACT OF 2002
        In connection with the accompanying Transition Report on Form 10-K/T of Caraco Pharmaceutical Laboratories, Ltd. (Caraco) for the three months ended March 31, 2005 (the Report), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their respective knowledge and belief, that:
        (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
        (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Caraco.
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

| | /s/  Daniel H. Movens                          
| | -----------------------------------------------
| |                                                
| | Daniel H. Movens
      Chief Executive Officer 
| |                                                
| | /s/  Jitendra N. Doshi                         
| |                                                
| | Jitendra N. Doshi
      Chief Financial Officer

|             
|-------------
|June 10, 2005

|
|